China’s Sinopharm says Covid-19 vaccine 79% effective
This is the first data released of a Chinese vaccine SAMAA | AFP - Posted: Dec 30, 2020 | Last Updated: 3 months ago SAMAA | AFP Posted: Dec 30, 2020 | Last Updated: 3 months ago
Photo: AFP
Listen to the story
Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79% effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna, but a potential breakthrough in the battle to stem the pandemic in Asia.
China, where the pandemic first emerged, has been racing against the West to develop its own Covid-19 vaccines, with five already in large-scale Phase 3 clinical trials but none officially approved yet.
The Latest: UAE shatters record for new daily infections milfordmirror.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from milfordmirror.com Daily Mail and Mail on Sunday newspapers.
BEIJING China is encouraging tens of millions of migrant workers not to travel home during February’s Lunar New Year holiday to prevent spread of the coronavirus.
The call issued by the National Health Commission is extraordinary because the Lunar New Year is China’s most important traditional holiday. It’s the only time of the year when many workers can travel home to see their families.
China has limited local transmission of the coronavirus, but authorities remain on high alert about a possible resurgence. Already, schools are scheduled to begin the Lunar New Year vacation a week early and tourists have been told not to visit Beijing during the holiday.
Views: Visits 18
A medical worker waits for the next individual to take a swab test for the COVID-19 coronavirus at a hospital in Beijing in December 30, 2020. Noel Celis / AFP
Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia.
China has been racing against the West to develop its own Covid-19 vaccines, with five already in large-scale Phase 3 clinical trials.
But Wednesday’s announced was the first data released regarding the efficacy of a Chinese vaccine candidate.